SQZ Biotechnologies Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- SQZ Biotechnologies's estimated annual revenue is currently $17.7M per year.
- SQZ Biotechnologies received $72.0M in venture funding in August 2018.
- SQZ Biotechnologies's estimated revenue per employee is $155,000
- SQZ Biotechnologies's total funding is $102.1M.
- SQZ Biotechnologies has 114 Employees.
- SQZ Biotechnologies grew their employee count by 2% last year.
- SQZ Biotechnologies currently has 8 job openings.
What Is SQZ Biotechnologies?
SQZ Biotech is a unique cell therapy company, utilizing the proprietary CellSqueeze® platform to develop a new generation of cell therapies. SQZ currently focuses on the development of novel treatments that leverage targeted immune modulation to impact oncology and autoimmune diseases. SQZ: Empower cells to change lives.keywords:Biotechnology,Healthcare,Pharmaceuticals